Disease ⇒ Biliary atresia {40000456}
Type: | Disease |
---|---|
Parent: | [ ] |
Definition: | Biliary atresia |
Initialisation date: | [ ] |
---|---|
Other Terms: | BA |
MedDra ID: | 10004653 |
---|---|
MedDra Level: | llt |
ICD: | [ ] |
Category: | [ ] |
Zone: | [ ] |
Mechanism: | [ ] |
Notes:
[ ]
Shared Reference Notes
- [1.1]
- #Butyrate administration to mothers > renders newborn mice resistant to inflammation and injury of bile ducts > improves survival. - Bacteroidetes and Clostridia and increases glutamate/#Glutamine and hypoxanthine in stool metabolites of newborn mice > prevention of hepatic immune cell activation and survival. - In human neonates with biliary atresia, the fecal microbiome signature of these bacteria is under-represented, with suppression of glutamate/#Glutamine and increased hypoxanthine pathways. - The direct administration of #Butyrate or #Glutamine to newborn mice attenuates the disease phenotype, but only #Glutamine renders bile duct epithelial cells resistant to cytotoxicity by natural killer cells. - [1.2] [#Primary sclerosing cholangitis]
- #Veillonella extensively participates in a range of diseases associated with gastrointestinal microbial dysbiosis, for instance, hepatic and gall diseases (#Autoimmune hepatitis, #Alcoholic Hepatitis, biliary atresia, and PSC)
References Notes
[ ]